Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis

Clinical trial NCT04689152 · RECRUITING

Trial details

NCT number: NCT04689152
Sponsor: Pharmicell Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Alcoholic Cirrhosis

Start date: 2021-03-02
Primary completion: 2027-08-02
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.